Phagelux to Develop Phage-Based Skin Care Antibacterials with J&J

Phagelux will collaborate with Johnson and Johnson Consumer to develop phage-based antibacterial skin care products. Phagelux, headquartered in Shanghai, but with labs in Nanjing and Montreal, is dedicated to developing novel phage and lysin antibacterial products. Bacteriophages are viruses that infect bacteria and destroy them, an alternative mechanism to normal antibiotics. Phagelux's work with J&J will be aimed at "one or more" bacteriophage skin care products that will address either difficult-to-address or antibiotic-resistant bacteria. More details.... Share this with colleagues: // //